FDAnews Drug Daily Bulletin

New Avastin Tests Add to Confusion Over Use in Breast Cancer

Jan. 31, 2012
In November, following an emotional public hearing some months earlier, the Food and Drug Administration withdrew approval for the cancer drug Avastin for patients with metastatic breast cancer — the late-stage, incurable form of the disease.
Los Angeles Times